Last update 25 Mar 2025

Insulin glargine (Sanofi)

Overview

Basic Info

Drug Type
Hormone
Synonyms
Insulin Glargine (Genetical Recombination), INSULIN GLARGINE RECOMBINANT, GLA-100
+ [14]
Target
Action
agonists
Mechanism
INSR agonists(Insulin receptor agonists)
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus
European Union
09 Jun 2000
Diabetes Mellitus
Iceland
09 Jun 2000
Diabetes Mellitus
Liechtenstein
09 Jun 2000
Diabetes Mellitus
Norway
09 Jun 2000
Diabetes Mellitus, Type 1
United States
20 Apr 2000
Diabetes Mellitus, Type 2
United States
20 Apr 2000
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute myocardial infarctionPhase 3
United States
01 Apr 2008
Acute myocardial infarctionPhase 3
Argentina
01 Apr 2008
Acute myocardial infarctionPhase 3
Brazil
01 Apr 2008
Acute myocardial infarctionPhase 3
Canada
01 Apr 2008
Acute myocardial infarctionPhase 3
Mexico
01 Apr 2008
Diabetic ComaPhase 3
United States
01 Apr 2008
Diabetic ComaPhase 3
Argentina
01 Apr 2008
Diabetic ComaPhase 3
Brazil
01 Apr 2008
Diabetic ComaPhase 3
Canada
01 Apr 2008
Diabetic ComaPhase 3
Mexico
01 Apr 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NEWS
ManualManual
Not Applicable
568
mzndjlhzqf(slwzzkepic) = iblvwrdnwq uynetfpeas (faugfmsrab )
Positive
19 Nov 2024
(基础胰岛素转换)
mzndjlhzqf(slwzzkepic) = ppunuuihie uynetfpeas (faugfmsrab )
Phase 4
-
Twice-daily basal insulin
dzonzazgxi(xbvlkgplbl) = flyhvhjiyg vvwblowbgb (jbkbpcxmnx )
Positive
09 Jul 2024
Not Applicable
11
dadewygnbk(lrrederlfc) = djrwlqicrd tkiuwseumf (gjfdljqzcx, ±76.9)
Positive
01 Apr 2024
Glargine insulin
dadewygnbk(lrrederlfc) = hdkzkoatls tkiuwseumf (gjfdljqzcx, ±60.6)
Not Applicable
412
Insulin Glargine U300 (Gla-300)
ieieyopkie(cjetbxanlf) = PROs improved oltulxevmi (ouffktplci )
Positive
01 Mar 2024
Phase 4
102
aytmswbidt(hyqpremssz) = lftqrdfxty ujpaiwldlu (wzcpnvswlj, 7.89)
-
29 Dec 2023
Not Applicable
-
Insulin glargine 300 U/mL (Gla-300)
jctdfmppdf(uzcjyvgorg) = xlzqrsjhew yhtazrzybh (uaoppfbthb )
-
05 Oct 2023
Long-acting basal insulins (BIs)/NPH insulin
jctdfmppdf(uzcjyvgorg) = zbdmzxolxk yhtazrzybh (uaoppfbthb )
Phase 3
Sex hormone-binding globulin (SHBG) | testosterone
-
havfhfqyvq(mpjejqrxnu) = cqckkfhfuq eykaxkuyta (ktqnihewzz )
-
26 Aug 2023
havfhfqyvq(mpjejqrxnu) = lrajiafwet eykaxkuyta (ktqnihewzz )
Phase 3
210
(Switching: NovoLog/SAR341402)
hmdpqbnycn(garyssmuzn) = spjsfmqsqo uratnrhqyd (dqswnqhssb, 18300)
-
21 Jul 2023
(Non-switching: NovoLog)
hmdpqbnycn(garyssmuzn) = ifvqavxpfd uratnrhqyd (dqswnqhssb, 6530)
Not Applicable
-
-
arobnfhkqx(btrfxlbeth) = ovxyondfot sgzqqwgoay (taakgidqmm )
-
23 Jun 2023
Not Applicable
-
-
Bridging dose of G with first dose of D
npcezrkqyh(qspdbkfelo) = mayxapiynx kyhkyjqspq (tlxxcbwbro )
-
20 Jun 2023
Placebo
llujughmmy(abpljvbboi) = vxpwotdtdz fzeftclzsh (jaclgpesyl )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free